C
CASI Pharmaceuticals, Inc. (CASI)
NGM – Real vaqt narxi. Valyuta: USD
0.21
+0.21 (0.00%)
Yopilishda: Feb 25, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
0.21
+0.21 (0.00%)
Yopilishda: Feb 25, 2026, 4:00 PM EDT
CASI Pharmaceuticals, Inc., biotexnologiya kompaniyasi, Xitoy Xalq Respublikasi, Qo'shma Shtatlar va xalqaro miqyosda terapevtik va farmatsevtika mahsulotlarini ishlab chiqadi va tijoratlashtiradi. U EVOMELA, melfalanning tomir ichiga yuboriladigan shaklini, shu jumladan, ildiz hujayralari transplantatsiyasidan oldin konditsioner davolash va ko'p miyelomali bemorlarni palliativ davolash uchun taklif etadi. Kompaniyaning ishlab chiqish jarayonidagi gematologiya/onkologiya aktivlari orasida CNCT19, avtologik CD19 CAR-T tadqiqot mahsuloti; BI-1206, qattiq o'smalar va qaytalangan/refrakter non-Xojkin limfomasini davolash uchun yangi anti-FcγRIIB antitelasi; CB-5339, yangi VCP/p97 ingibitori, u valozin-o'z ichiga olgan oqsil (VCP)/p97 ni oqsil gomostazi, DNT shikastlanishiga javob va boshqa hujayra stress yo'llarida yangi maqsad sifatida ko'rib chiqadi, turli malignansiyalari bo'lgan bemorlarni davolash uchun; CID-103, inson IgG1 anti-CD38 monoklonal antikori; va Thiotepa, kimyoterapiya vositasi, turli ko'rsatmalarga ega, shu jumladan, ba'zi allogenik gematopoetik ildiz hujayralari transplantatsiyasidan oldin konditsioner davolash sifatida foydalanish. Kompaniya Juventas Cell Therapy Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; va Acrotech Biopharma L.L.C. bilan litsenziyalash shartnomalariga ega. uni tijoriy mahsuloti EVOMELA ni ishlab chiqish va tijoratlashtirish uchun. CASI Pharmaceuticals, Inc. 1991 yilda tashkil etilgan va Xitoy Xalq Respublikasining Pekin shahrida joylashgan.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-28 | D | |
| 2026-01-22 | 6-K | tm262912d2_6k.htm |
| 2026-01-13 | 6-K | tm262912d1_6k.htm |
| 2025-12-31 | 6-K | tm2534488d1_6k.htm |
| 2025-12-23 | 6-K | tm2534203d1_6k.htm |
| 2025-12-11 | 6-K | tm2533078d1_6k.htm |
| 2025-11-19 | 6-K | tm2531587d1_6k.htm |
| 2025-11-14 | 6-K | tm2530997d1_6k.htm |
| 2025-11-10 | 6-K | tm2530719d1_6k.htm |
| 2025-09-26 | 6-K | tm2527019d1_6k.htm |